Full Press Release Details
CRISPR Therapeutics and Vertex to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition.
CRSP
CRISPR Therapeutics and Vertex to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition
Key Takeaway: CRISPR Therapeutics and Vertex to Present at the American Society of Hematology (ASH) Annual Meeting and Exposition
Price reaction · baseline $48.99 (2022-12-09 close) · hit after-hours · 1 other CRSP headline(s) in the window, move may be shared
day 0 close · peak
+4.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension